- $8.27bn
- $8.94bn
- $1.20bn
- 95
- 34
- 78
- 79
Annual balance sheet for HealthEquity, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 329 | 225 | 254 | 404 | 296 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 72.8 | 87.4 | 96.8 | 105 | 118 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 460 | 351 | 383 | 557 | 478 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 119 | 87 | 69.3 | 54.4 | 46.4 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,710 | 3,107 | 3,089 | 3,164 | 3,449 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 205 | 153 | 131 | 117 | 156 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,332 | 1,255 | 1,193 | 1,129 | 1,334 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1,379 | 1,853 | 1,896 | 2,035 | 2,115 |
| Total Liabilities & Shareholders' Equity | 2,710 | 3,107 | 3,089 | 3,164 | 3,449 |
| Total Common Shares Outstanding |